The impact of [F-18]fludeoxyglucose PET/CT in small-cell lung cancer: analysis of the phase 3 CONVERT trial
Authors
Manoharan, PrakashSalem, Ahmed
Mistry, Hitesh
Gornall, Michael
Harden, S
Julyan, Peter J
Locke, I
Mcaleese, J
Mcmenemin, R
Mohammed, N
Snee, M
Westwood, Thomas D
Woods, S
Faivre-Finn, Corinne
Affiliation
Department of Radiology, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2018
Metadata
Show full item recordCitation
Manorharan P, Salem A, Mistry H, Gornall M, Harden S, Julyan P, et al. OA13.01 The impact of [F-18]fludeoxyglucose PET/CT in small-cell lung cancer: analysis of the phase 3 CONVERT trial. J Thorac Oncol. 2018;13(10):S351.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2018.08.306Additional Links
https://dx.doi.org/10.1016/j.jtho.2018.08.306Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2018.08.306